|
DPH3B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.77629999989593E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83935999999996E-05 |
| Normal-vs-Stage2 |
1.517440E-01 |
| Normal-vs-Stage3 |
2.06139999958665E-07 |
| Normal-vs-Stage4 |
1.04160000002906E-06 |
| Stage1-vs-Stage2 |
7.114800E-01 |
| Stage1-vs-Stage3 |
4.561800E-02 |
| Stage1-vs-Stage4 |
1.584390E-01 |
| Stage2-vs-Stage3 |
2.860600E-01 |
| Stage2-vs-Stage4 |
3.646200E-01 |
| Stage3-vs-Stage4 |
7.404000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.64279999948347E-07 |
| Normal-vs-AfricanAmerican |
3.89109999999748E-05 |
| Normal-vs-Asian |
9.685600E-01 |
| Caucasian-vs-AfricanAmerican |
5.308200E-01 |
| Caucasian-vs-Asian |
1.455250E-01 |
| AfricanAmerican-vs-Asian |
5.185600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.11250000003993E-06 |
| Normal-vs-Female |
2.36720000046375E-07 |
| Male-vs-Female |
5.955800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.909230E-01 |
| Normal-vs-Age(41-60Yrs) |
5.385400E-04 |
| Normal-vs-Age(61-80Yrs) |
8.28339952185786E-10 |
| Normal-vs-Age(81-100Yrs) |
2.964700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.632600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.251600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.047900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.063670E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.593400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.650800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.456000E-01 |
| Normal-vs-Grade 2 |
6.379800E-04 |
| Normal-vs-Grade 3 |
1.10599995828409E-09 |
| Normal-vs-Grade 4 |
3.70619999999766E-05 |
| Grade 1-vs-Grade 2 |
8.477700E-02 |
| Grade 1-vs-Grade 3 |
6.600700E-03 |
| Grade 1-vs-Grade 4 |
3.861700E-02 |
| Grade 2-vs-Grade 3 |
6.096800E-03 |
| Grade 2-vs-Grade 4 |
2.502600E-01 |
| Grade 3-vs-Grade 4 |
2.480400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.76950051570202E-10 |
| Normal-vs-ccB subtype |
3.404100E-03 |
| ccA subtype-vs-ccB subtype |
7.403400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.66910000001896E-06 |
| Normal-vs-N1 |
3.305700E-02 |
| N0-vs-N1 |
8.814800E-01 |
|
|
